UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent

Journal of hepatology, 2015-09, Vol.63 (3), p.564-572

2015

Volltextzugriff (PDF)

Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma

Digestive diseases and sciences, 2017-03, Vol.62 (3), p.784-793

2017

Volltextzugriff (PDF)

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

The Lancet (British edition), 2019-04, Vol.393 (10181), p.1597-1608

2019

Volltextzugriff (PDF)

Development of hyperdynamic circulation and response to β‐blockers in compensated cirrhosis with portal hypertension

Hepatology (Baltimore, Md.), 2016-01, Vol.63 (1), p.197-206

2016

Volltextzugriff (PDF)

Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis c

Journal of hepatology, 2017-04, Vol.66 (4), p.718-723

2017

Volltextzugriff (PDF)

Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection

Journal of hepatology, 2011-06, Vol.54 (6), p.1114-1122

2011

Volltextzugriff (PDF)

Efficacy and Pharmacokinetics of Glecaprevir and Pibrentasvir With Concurrent Use of Acid-Reducing Agents in Patients With Chronic HCV Infection

Clinical gastroenterology and hepatology, 2019-02, Vol.17 (3), p.527-535.e6

2019

Volltextzugriff (PDF)

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa‐2a plus ribavirin

Hepatology (Baltimore, Md.), 2009-12, Vol.50 (6), p.1702-1708

2009

Volltextzugriff (PDF)

Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis

PloS one, 2015-09, Vol.10 (9), p.e0138503-e0138503

2015

Volltextzugriff (PDF)

Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE Study

Journal of clinical gastroenterology, 2016-10, Vol.50 (9), p.779-789

2016

Volltextzugriff (PDF)

PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C

Annals of hepatology, 2014-07, Vol.13 (4), p.356-363

2014

Volltextzugriff (PDF)

Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata

Scandinavian journal of gastroenterology, 2014-10, Vol.49 (10), p.1181-1190

2014

Volltextzugriff (PDF)

High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4

Liver international, 2017-12, Vol.37 (12), p.1823-1832

2017

Volltextzugriff (PDF)

Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild‐moderate fibrosis: Results from a real‐world cohort

Liver international, 2019-01, Vol.39 (1), p.90-97

2019

Volltextzugriff (PDF)

Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061

Antiviral therapy, 2006-01, Vol.11 (3), p.371-376

2006

Volltextzugriff (PDF)

Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole

Digestive diseases and sciences, 2005-03, Vol.50 (3), p.432-439

2005

Volltextzugriff (PDF)

Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities

European journal of gastroenterology & hepatology, 2015-01, Vol.27 (1), p.46-54

2015

Volltextzugriff (PDF)

STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk

Annals of the rheumatic diseases, 2009-11, Vol.68 (11), p.1746-1753

2009

Volltextzugriff (PDF)

Localized lymphadenitis due to leishmania. Diagnosis by fine needle aspiration cytology

Postgraduate medical journal, 1990-04, Vol.66 (774), p.326-326

1990

Volltextzugriff (PDF)

Preemptive‐TIPS Improves Outcome in High‐Risk Variceal Bleeding: An Observational Study

Hepatology (Baltimore, Md.), 2019-01, Vol.69 (1), p.282-293

2019

Volltextzugriff (PDF)

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

Journal of hepatology, 2016-04, Vol.64 (4), p.800-806

2016

Volltextzugriff (PDF)

Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease

JAMA : the journal of the American Medical Association, 2024-04, Vol.331 (15), p.1287

2024

Volltextzugriff (PDF)

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

The Lancet (British edition), 2023-11, Vol.402 (10415), p.1835-1847

2023

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(57)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(57)
Male
(53)
Female
(52)
Middle Aged
(51)
Science & Technology
(50)
Life Sciences & Biomedicine
(49)
Aged
(36)
Gastroenterology & Hepatology
(24)
Biological And Medical Sciences
(21)
Medical Sciences
(19)
Aged, 80 And Over
(17)
Treatment Outcome
(15)
Antiviral Agents - Therapeutic Use
(13)
Young Adult
(13)
Hepatitis C, Chronic - Drug Therapy
(11)
Drug Therapy, Combination
(10)
Hepacivirus - Genetics
(10)
Pharmacology. Drug Treatments
(10)
Retrospective Studies
(10)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent

Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

Development of hyperdynamic circulation and response to β‐blockers in compensated cirrhosis with portal hypertension

Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis c

Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection

Efficacy and Pharmacokinetics of Glecaprevir and Pibrentasvir With Concurrent Use of Acid-Reducing Agents in Patients With Chronic HCV Infection

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa‐2a plus ribavirin

Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis

Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE Study

PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C

Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata

High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4

Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild‐moderate fibrosis: Results from a real‐world cohort

Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061

Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole

Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities

STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk

Localized lymphadenitis due to leishmania. Diagnosis by fine needle aspiration cytology

Preemptive‐TIPS Improves Outcome in High‐Risk Variceal Bleeding: An Observational Study

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B

Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B

Aktive Filter

Suchergebnisse filtern